MacroGenics (NASDAQ:MGNX): Q3 GAAP EPS of -$0.91 beats by $0.02.
Revenue of $18.74M (-9.9% Y/Y) beats by $3.48M.
Shares -4.42%.
Wednesday, November 6, 2019
Emergent Biosolutions EPS beats by $0.26, beats on revenue
Emergent Biosolutions (NYSE:EBS): Q3 Non-GAAP EPS of $1.21; GAAP EPS of $0.83 beats by $0.26.
Revenue of $311.8M (+79.6% Y/Y) beats by $22.64M.
Nektar Therapeutics EPS beats by $0.17, beats on revenue
Nektar Therapeutics (NASDAQ:NKTR): Q3 GAAP EPS of -$0.56 beats by $0.17.
Revenue of $29.2M (+5.2% Y/Y) beats by $2.78M.
AxoGen EPS beats by $0.04, beats on revenue
Revenue of $28.56M (+26.0% Y/Y) beats by $0.24M.
Shares +2.03%.
PDL BioPharma EPS misses by $0.21, beats on revenue
PDL BioPharma (NASDAQ:PDLI): Q3 GAAP EPS of -$0.16 misses by $0.21.
Revenue of $44.2M (-34.9% Y/Y) beats by $10.34M.
Collegium Pharmaceutical EPS misses by $0.03, misses on revenue
Collegium Pharmaceutical (NASDAQ:COLL): Q3 GAAP EPS of -$0.18 misses by $0.03.
Revenue of $72.94M (+3.9% Y/Y) misses by $1.38M.
Globus Medical EPS beats by $0.01, beats on revenue
Globus Medical (NYSE:GMED): Q3 Non-GAAP EPS of $0.43 beats by $0.01; GAAP EPS of $0.38 misses by $0.01.
Revenue of $196.22M (+15.9% Y/Y) beats by $10.36M.
Subscribe to:
Comments (Atom)